UK experts are now recommending that all teenagers aged 15 should receive the MenB vaccine for better protection against meningitis B. This shift in guidance comes in response to a significant outbreak in Kent earlier this year, which tragically resulted in two deaths. The Joint Committee on Vaccination and Immunisation (JCVI) believes that routine vaccination could prevent future outbreaks by immunising adolescents who are at higher risk due to social behaviours such as close contact and sharing drinks.
Currently, the MenB vaccine is administered to infants, but older teens have not been routinely vaccinated. The JCVI’s new recommendation suggests that those aged 15 should receive two doses, while those who were vaccinated as babies would only need a single booster. The financial implications for the NHS remain a critical factor, as ministers will need to assess whether the benefits outweigh the costs of implementing this vaccination programme.
As a precautionary measure, a one-off vaccination campaign is being launched this summer for young people heading to university, helping to protect those at the highest risk. The JCVI’s decision is influenced by recent evidence highlighting the severe consequences of MenB infections, which can lead to life-altering disabilities or death.
This recommendation could significantly change the landscape of adolescent healthcare in the UK, potentially saving lives and preventing serious health complications associated with meningitis B. Parents are encouraged to stay informed about vaccination options for their children as these changes unfold.
Source: BBC News
